Canadian National [CNI] vs CSX [CSX] Detailed Stock Comparison
Canadian National
NYSE
Loading...
CSX
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Canadian National wins in 16 metrics, CSX wins in 4 metrics, with 0 ties. Canadian National appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Canadian National | CSX | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 17.53 | 21.74 | Canadian National |
| Price-to-Book Ratio | 2.69 | 5.34 | Canadian National |
| Debt-to-Equity Ratio | 97.21 | 159.51 | Canadian National |
| PEG Ratio | 15.61 | 17.45 | Canadian National |
| EV/EBITDA | 8.91 | 12.87 | Canadian National |
| Profit Margin (TTM) | 26.62% | 21.92% | Canadian National |
| Operating Margin (TTM) | 41.29% | 36.09% | Canadian National |
| EBITDA Margin (TTM) | 41.29% | 36.09% | Canadian National |
| Return on Equity | 22.30% | 24.82% | CSX |
| Return on Assets (TTM) | 7.75% | 7.25% | Canadian National |
| Free Cash Flow (TTM) | $3.15B | $2.72B | Canadian National |
| Dividend Yield | 1.81% | 1.83% | CSX |
| 1-Year Return | -16.48% | 4.21% | CSX |
| Price-to-Sales Ratio (TTM) | 3.38 | 4.67 | Canadian National |
| Enterprise Value | $57.06B | $85.41B | CSX |
| EV/Revenue Ratio | 4.58 | 6.03 | Canadian National |
| Gross Profit Margin (TTM) | 42.77% | 35.90% | Canadian National |
| Revenue per Share (TTM) | $27 | $7 | Canadian National |
| Earnings per Share (Diluted) | $5.28 | $1.63 | Canadian National |
| Beta (Stock Volatility) | 0.86 | 1.25 | Canadian National |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Canadian National vs CSX Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Canadian National | 0.09% | -0.31% | -11.80% | -8.65% | -9.69% | -9.12% |
| CSX | 0.51% | 1.20% | 6.11% | 22.34% | 7.10% | 10.17% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Canadian National | -16.48% | -27.79% | -9.67% | 49.69% | 205.51% | 446.46% |
| CSX | 4.21% | 3.14% | 43.15% | 258.97% | 532.68% | 1,328.63% |
Performance & Financial Health Analysis: Canadian National vs CSX
| Metric | CNI | CSX |
|---|---|---|
| Market Information | ||
| Market Cap | $57.87B | $66.05B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,581,990 | 18,518,020 |
| 90 Day Avg. Volume | 1,674,763 | 18,119,080 |
| Last Close | $92.57 | $35.43 |
| 52 Week Range | $91.65 - $121.12 | $26.22 - $37.10 |
| % from 52W High | -23.57% | -4.50% |
| All-Time High | $137.19 (Mar 28, 2022) | $40.12 (Feb 19, 2024) |
| % from All-Time High | -32.52% | -11.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | -0.03% |
| Quarterly Earnings Growth | 0.05% | -0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.27% | 0.22% |
| Operating Margin (TTM) | 0.41% | 0.36% |
| Return on Equity (TTM) | 0.22% | 0.25% |
| Debt to Equity (MRQ) | 97.21 | 159.51 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $34.44 | $6.64 |
| Cash per Share (MRQ) | $0.35 | $0.21 |
| Operating Cash Flow (TTM) | $4.85B | $4.96B |
| Levered Free Cash Flow (TTM) | $1.67B | $1.55B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.81% | 1.83% |
| Last 12-Month Dividend | $1.84 | $0.63 |
Valuation & Enterprise Metrics Analysis: Canadian National vs CSX
| Metric | CNI | CSX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 17.53 | 21.74 |
| Forward P/E | 15.61 | 17.45 |
| PEG Ratio | 15.61 | 17.45 |
| Price to Sales (TTM) | 3.38 | 4.67 |
| Price to Book (MRQ) | 2.69 | 5.34 |
| Market Capitalization | ||
| Market Capitalization | $57.87B | $66.05B |
| Enterprise Value | $57.06B | $85.41B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.58 | 6.03 |
| Enterprise to EBITDA | 8.91 | 12.87 |
| Risk & Other Metrics | ||
| Beta | 0.86 | 1.25 |
| Book Value per Share (MRQ) | $34.44 | $6.64 |
Financial Statements Comparison: Canadian National vs CSX
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CNI | CSX |
|---|---|---|
| Revenue/Sales | $4.40B | $3.42B |
| Cost of Goods Sold | $2.63B | $2.38B |
| Gross Profit | $1.78B | $1.04B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $1.61B | $1.04B |
| EBITDA | $2.25B | $1.49B |
| Pre-Tax Income | $1.53B | $858.00M |
| Income Tax | $366.00M | $212.00M |
| Net Income (Profit) | $1.16B | $646.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CNI | CSX |
|---|---|---|
| Cash & Equivalents | $232.00M | $1.14B |
| Total Current Assets | $2.68B | $3.02B |
| Total Current Liabilities | $4.31B | $3.42B |
| Long-Term Debt | $19.34B | $19.01B |
| Total Shareholders Equity | $21.62B | $12.18B |
| Retained Earnings | $18.88B | $9.66B |
| Property, Plant & Equipment | $48.90B | $53.16B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CNI | CSX |
|---|---|---|
| Operating Cash Flow | $1.27B | $1.17B |
| Capital Expenditures | $-519.00M | $-750.00M |
| Free Cash Flow | $645.00M | $-141.00M |
| Debt Repayment | $-5.64B | $-1.00M |
| Common Stock Repurchase | $-162.00M | $-421.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CNI | CSX |
|---|---|---|
| Shares Short | 6.32M | 23.54M |
| Short Ratio | 4.52 | 1.69 |
| Short % of Float | N/A | 0.01% |
| Average Daily Volume (10 Day) | 1,581,990 | 18,518,020 |
| Average Daily Volume (90 Day) | 1,674,763 | 18,119,080 |
| Shares Outstanding | 627.93M | 1.90B |
| Float Shares | 606.89M | 1.86B |
| % Held by Insiders | 0.03% | 0.00% |
| % Held by Institutions | 0.75% | 0.80% |
Dividend Analysis & Yield Comparison: Canadian National vs CSX
| Metric | CNI | CSX |
|---|---|---|
| Last 12-Month Dividend | $1.84 | $0.63 |
| Last 12-Month Dividend Yield | 1.81% | 1.83% |
| 3-Year Avg Annual Dividend | $2.17 | $0.50 |
| 3-Year Avg Dividend Yield | 0.52% | 0.35% |
| 3-Year Total Dividends | $6.52 | $1.51 |
| Ex-Dividend Date | Mar 10, 2025 | Aug 29, 2025 |